A federal review is underway that could reclassify 14 peptides into FDA Category 1. This change that may influence how peptide therapies are accessed in the U.S. Here's what experts are Dihexa 10mg Capsules Cognitive Research Support Peptide Pure Bio Labs The FDA's Category 2 list restricted 19 peptides from compounding. Now, approximately 14 of them may be coming back. HHS has signaled that peptides previously barred from compounding spanning categories like Nine Anticipated FDA Approvals for January 2026 Guideline Central